TRACY ROCKEFELLER: Open Payments
NPI 1346472057 · LAKEVILLE, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,077 in 82 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $293 · 2025 $2,077
Food & beverage: $2,077
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 13 | $329 |
| ABBVIE INC. | 8 | $288 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 10 | $280 |
| Otsuka America Pharmaceutical, Inc. | 9 | $239 |
| E.R. Squibb & Sons, L.L.C. | 7 | $191 |
| Axsome Therapeutics, Inc. | 3 | $157 |
| Collegium Pharmaceutical, Inc. | 8 | $131 |
| Vanda Pharmaceuticals Inc. | 4 | $120 |
| Teva Pharmaceuticals USA, Inc. | 5 | $94 |
| Alkermes, Inc. | 5 | $83 |
Products named: INGREZZA, VRAYLAR, CAPLYTA, COBENFY, REXULTI, Auvelity, Jornay PM, FANAPT.
Industry payments across PA — which companies pay providers there.
